Liver transplantation and HBsAg-positive postnecrotic cirrhosis: Adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis

Journal of Hepatology

Volumn 30, Issue 4, 1999, Pages 706-714

  Lerut, Jan P ^a   Donataccio, Matteo ^a   Ciccarelli, Olga ^a   Roggen, Francine ^a   Jamart, Jacques ^d   Laterre, Pierre François ^b   Cornu, Chantal ^a   Mazza, Davide ^a   Hanique, Geneviève ^b   Rahier, Jacques ^a   Geubel, André P ^c   Otte, Jean Bernard ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Cathol Univ L   (Belgium)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^d Departments of   (Belgium)

Author keywords

Allograft infection; Hepatitis B virus; Hepatitis delta virus; Hepatocellular cancer; Immunoprophylaxis; Liver transplantation; Recurrent disease

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ALLOGRAFT; ARTICLE; FEMALE; HEPATITIS DELTA VIRUS; HUMAN; HUMAN TISSUE; IMMUNOPROPHYLAXIS; LIVER CANCER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; VIRUS REPLICATION;

EID: 0033040469     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80203-7     Document Type: Article

References (58)

1. Demetris A.J., Jaffe R., Sheahan D.G., Burnham J., Ba H.T., Spero J., et al. Recurrent hepatitis B in liver allograft recipients. Am J Pathol. 125:1986;161-172.
2. Lake J.R., Wright T.H. Liver transplantation for patients with hepatitis B: what have we learned from our results? Hepatology. 13:1991;796-799.
3. Lucey M.R., Graham D.M., Martin P., DiBisceglie A., Rosenthal S., Waggoner J.G., et al. Recurrence of hepatitis B and delta hepatitis after orthotopic liver transplantation. Gut. 33:1992;1390-1396.
4. Martin P., Munoz S.J., Friedman L.S. Liver transplantation for viral hepatitis: current status. Am J Gastroenterol. 87:1992;409-418.
5. O'Grady J.G., Smith H.M., Davies S.E., Daniels H.M., Donaldson P.T., Tan K.C., et al. Hepatitis B virus reinfection after orthotopic liver transplantation. J Hepatol. 14:1992;104-111.
6. Todo S., Demetris A.J., Van Thiel D., Tepperman L., Fung J.J., Starzl T.E. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology. 13:1991;619-626.
7. Bismuth A., Arulnaden J.L., Samuel D., David M.F., Pichon F., Mathieu D., et al. Prophylaxie des récidives chez les transplantés hépatiques pour atteinte hépatique due au virus de l'hépatite B. Rev Fr Transfus Hemobiol. 35:1992;107-123.
8. Guggenheim J., Crafa F., Fabiani P., Goubaux B., Ouzan, Mouiel J. Long-term passive immunoprophylaxis of B virus reccurence after liver transplantation in HBs-antigen-positive patients. Transplant Proc. 25:1993;1349-1350.
9. Hopf U., Neuhaus P., Konig V., Bauditz J., Kuther S., Schmidt C.A., et al. Risk and prophylaxis in orthotopic liver transplantation and persistent infection with hepatitis B and B-Delta virus. Z Artzl Fortb. 86:1992;861-868.
10. Muller R., Gubernatis G., Farle M., Niehoff G., Klein H., Wittekind Ch, et al. Liver transplantation in HBs antigen carriers. J Hepatol. 13:1991;90-96.
11. Samuel D., Bismuth A., Mathieu D., Arulnaden J.L., Reynes M., Benhamou J.P., et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet. 337:1991;813-815.
12. Demetris A.J., Todo S., Van Thiel D.H., Fung J.J., Iwaki Y., Sysyn G., et al. Evolution of hepatitis B virus liver disease after hepatic replacement. Am J Pathol. 137:1990;667-676.
13. Kuhns M.C., McNamara A.L., Cabal C.M., Decker R.H., Thiers V., Brechot C., et al. A new assay for the quantitative detection of hepatitis B viral DNA in human serum. Zuckerman A.G., Viral Hepatitis and Liver Disease. 1988;258-262 AR Liss, Inc, New York.
14. Bianchi L., Gudat F. Chronic hepatitis. McSween R., Anthony P., Scheuer P.J., Burt A.D., Portmann B., Pathology of the Liver. 1995;377-381 Churchill Livingstone, London.
15. Phillips M.J., Cameron R., Flowers M.A., Blendis L.M., Greig P.D., Wanless J., et al. Post-transplant recurrent hepatitis B viral liver disease. Am J Pathol. 140:1992;1295-1308.
16. Wright T.L., Mamish D., Combs C., Kim M., Donegan E., Ferrell L., et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet. 339:1992;952-955.
17. Lake J.R. Should liver transplantation be performed for patients with chronic hepatitis B? Yes. Liver Transplant Surg. 1:1995;260-265.
18. Feray C., Zignego A.L., Samuel D., Bismuth A., Reynes M., Tiollais P., et al. Persistant hepatitis B-virus infection of mononuclear cells without concomitant liver infection: the liver transplantation model. Transplantation. 49:1990;1155-1158.
19. Chiu-Ching Huang, Ming-Kuen Lai, Man-Tat Fong. Hepatitis B liver disease in cyclosporine-treated renal allograft recipients. Transplantation. 49:1990;540-544.
20. Parfrey P.S., Frobes R.D.C., Hutchinson T.A. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients. Transplantation. 37:1984;461-466.
21. Lewis J.H., El-Ashmawy L., Ramsey G.E., Bontempo F.A., Rochlani M., Demetris P.J., et al. Hepatitis viral markers in patients under-going primary liver transplants. Dig Dis Sci. 38:1993;457-461.
22. Freeman R.B., Sanchez H., Lewis D.W., Sherburne B., Dzik W.H., Khettry U., et al. Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation. Transplantation. 51:1991;793-797.
23. Lau J.Y.N., Bain V.G., Davies S.E., O'Grady J.G., Alberti A., Alexander G.J.M., et al. High level expression of hepatitis-B after liver transplantation. Gastroenterology. 102:1992;956-962.
24. Crippin J.S., Foster B., Carlen S.L., Borcich A., Bodenheimer H.C. Retransplantation in hepatitis B - a multicentre experience. Transplantation. 57:1994;823-826.
25. Hopf U., Neuhaus P., Lobeck H., Konig V., Kuther S., Bauditz J., et al. Follow-up of recurrent hepatitis B and delta infection in liver allograft recipients after treatment with recombinant interferon. J Hepatol. 13:1991;339-346.
26. Benner K.G., Lee R.G., Keeffe E.B., Lopez R., Sasaki A., Pinson C.W. Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. Gastroenterology. 103:1992;1307-1312.
27. Samuel D., Muller R., Alexander G., Fassati L., Ducot B., Benhamou J.P., et al. Liver transplantation in European patients with hepatitis B surface antigen. N Engl J Med. 329:1993;1842-1847.
28. Ottobrelli A., Marzano A., Smedile A., Recchia S., Salizzoni M., Cornu C., et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology. 101:1992;1649-1655.
29. Samuel D., Zignego A.L., Reynes M., Feray C., Arulnaden J.L., David M.F., et al. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis. Hepatology. 21:1995;333-339.
30. Zignego A.L., Samuel D., Gentilini P., Bismuth H. Patterns and mechanisms of hepatitis B/hepatitis D reinfection after liver transplantation. Arch Virol. 8:1993;281-289.
31. David E., Rahier J., Pucci A., Camby Ph, Scevens M., Salizzoni M., et al. Recurrence of hepatitis D in liver transplants: histopathological aspects. Gastroenterology. 104:1993;1122-1128.
32. Zarski J.P., Marcellin I., Cohard M., Lutz J.M., Bouche C., Rais A., a French Multicenter Group . Comparison of anti-HBe positive and HBe-antigen positive chronic hepatitis B in France. J Hepatol. 20:1994;636-640.
33. Angus P.W., Locarnini StA, McCaughan G.W., Jones R.M., McMillan J.S., Bowden D. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology. 21:1995;14-18.
34. Konig V., Hopf U., Neuhaus I., Bauditz J., Schmidt C.A., Blumhardt G., et al. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation. 58:1994;553-559.
35. McGory R., Ishitani M., Oliveira W., Stevenson W., McCullough C., Dickson R., et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation. 61:1996;1358-1364.
36. Eason J.D., Freeman R., Rohrer R.J., Lewis W.D., Jenkins R., Dienstag J., et al. Should liver transplantation be performed for patients with hepatitis B. Transplantation. 57:1994;1588-1593.
37. Mazzaferro V., Regalia E., Montalto F., Pulvirenti A., Brunetto M.R., Bonino F., et al. Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary hepatocellular carcinoma is not a predictor for HBV recurrence. Liver. 16:1996;117-122.
38. Wong P.Y., McPeake J.R., Portmann B., Tan K.C., Naoumov N.V., Williams R. Clinical course and survival after liver transplantation for hepatitis B virus infection complicated by hepatocellular carcinoma. Am J Gastroenterol. 90:1995;29-34.
39. McMahon G., Ehrlich P.H., Moustafa Z.A., McCarthy L.A., Dottavio D., Tolpin M.D., et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant recipients. Hepatology. 15:1992;757-766.
40. Devlin J., Smith H.M., O'Grady J.G., Portmann B., Tan K.C., Williams R. Impact of immunoprophylaxis and patient selection on outcome of transplantation for HBsAg-positive liver recipients. J Hepatol. 21:1994;204-210.
41. Terrault N.A., Wright T.L. Therapy for chronic hepatitis B infection. Adv Exp Med Biol. 394:1996;189-205.
42. Kiyasu P.K., Ishitani M.B., McGory R.W., Gaffey M.S., Dickson R.C., Caldwell S.H., et al. Prevention of hepatitis B recurrence after a second liver transplant - the role of maintenance polyclonal HBIg therapy. Transplantation. 58:1994;954-956.
43. Mentha G., Giostra E., Perrin L., Widmann J.J., Stelling M., Easton J., et al. Prevention of viral recurrence following liver transplantation for post-hepatitis B and B-delta cirrhosis. Schweiz Med Wochenschr. 124:1994;637-641.
44. Laskus T., Rakela J., Steers J.L., Wiesner R.H., Persing D.H. Precore and contiguous regions of hepatitis B virus in liver transplantation for end-stage hepatitis B. Gastroenterology. 107:1994;1774-1780.
45. Hawkins A.E., Gilson R.J.C., Gilbert N., Wreghitt T.G., Gray J.J., Ahlers-de Boer I., et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. Hepatology. 24:1996;8-14.
46. McMillan J.S., Bowden D.S., Angus P.W., McCaughan G.W., Locarnini S.A. Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation. Hepatology. 24:1996;1371-1378.
47. Padbury R.T., Gunson B.K., Dousset B., Hubscher S.G., Buckels J.A., Neuberger J.M., et al. Steroid withdrawal from long-termimmuno-suppression in liver allograft recipients. Transplantation. 55:1993;789-794.
48. Lau J Y.N., Bain V.G., Smith H.M., Alexander G.J.M., Williams R. Modulation of hepatitis B viral antigen expression by immuno-suppression drugs in primary hepatocyte culture. Transplantation. 53:1992;894-898.
49. Tur-Kaspa R., Burk R.D., Shaul Y., Shafritz D.A. Hepatitis B-virus DNA contains a glucocorticoid-responsive element. Proc Natl Acad Sci USA. 83:1986;1627-1631.
50. Adams D.H., Hubscher S.G., Neuberger J.M., McMaster P., Elias E., Buckels J.A.C. Reduced incidence of rejection in patients under-going liver transplantation for chronic hepatitis B. Transplant Proc. 23:1991;1436-1437.
51. Farges O., Saliba F., Farhamart H., Samuel D., Bismuth A., Reynes M., et al. Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins. Hepatology. 23:1996;240-248.
52. Tchervenkov J.I., Tector J., Barkun J.S., Sherker A., Forbes C.L.D., Elias N., et al. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon alpha pretransplant and hepatitis B immune globulin posttransplant. Ann Surg. 226:1997;356-368.
53. Lavine J.E., Lake J.R., Ascher N.L., Ferrell L.D., Ganem D., Wright T.L. Persistent hepatitis B virus following interferon alfa therapy and liver transplantation. Gastroenterology. 100:1991;263-267.
54. Neuhaus P., Steffen R., Blumhardt G., Bechstein W., Keck H., Lemmens H.P., et al. Experience with immunoprophylaxis and interferon therapy after liver transplantation in HBsAg positive patients. Transplant Proc. 23:1991;1522-1524.
55. Wright H.I., Gavaler J.S., Van Thiel D.H. Preliminary experience with α2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation. 53:1992;121-124.
56. Marcellin P., Samuel D., Areias J., Loriot M.A., Arulnaden J.L., Gigou M., et al. Pretransplantation interferon treatment and recurrence of hepatitis B virus infection after liver transplantation for hepatitis B-related end-stage liver disease. Hepatology. 19:1994;6-12.
57. Tine F., Liberati A., Craxi A., Almasio P., Pagliaro L. Interferon treatment on patients with chronic hepatitis B: a meta-analysis of the published literature. J Hepatol. 18:1993;154-162.
58. Kruger M., Tillmann H.L., Trautwein R., Bode U., Oldhafer K., Maschek H., et al. Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: a pilot study. Liver Transplant Surg. 2:1996;253-263.